Understanding of Genetics by Men at Risk for Prostate Cancer

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Mayo Clinic
Study ID
NCT04550845
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
40 Years - 95 Years
Healthy Volunteers
Accepted

Interventions

  • Focus group analyses — BEHAVIORAL
    Focus group audiotapes will be transcribed verbatim, and then entered into the qualitative data software package, NVivo 14 for analysis.

Study Details

With this greater certainty regarding prognosis, men with localized prostate cancer are now equipped with make better treatment planning decisions. This study is designed to investigate the understanding of prognostic genetic technology in African American and rural White men at risk for localized prostate cancer.

Key Dates

Start date
May 1, 2023
Status verified
Oct 2025
Primary completion
Sep 27, 2027
Completion
Sep 27, 2027

Study Design

Enrollment
90 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video.
    Focus group discussions about the PCGLA educational video post-study. Focus group audiotapes will be transcribed verbatim, and then entered into the qualitative data software package, NVivo 14. A data dictionary will be created for each technical term to establish acceptable and unacceptable responses. Trained coders will evaluate comprehension of the technical terms independently and then resolve disagreement by consensus.
  • Experimental: Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video plus Communication Coaching.
    Focus group discussions about the PCGLA educational plus nurse-navigated, tailored, prostate cancer education and communication coaching post-study. Focus group audiotapes will be transcribed verbatim, and then entered into the qualitative data software package, NVivo 14. A data dictionary will be created for each technical term to establish acceptable and unacceptable responses. Trained coders will evaluate comprehension of the technical terms independently and then resolve disagreement by consensus. post-study. Focus group audiotapes will be transcribed verbatim, and then entered into the qualitative data software package, NVivo 14. A data dictionary will be created for each technical term to establish acceptable and unacceptable responses. Trained coders will evaluate comprehension of the technical terms independently and then resolve disagreement by consensus.

Primary Outcome Measure

Estimate Genetic Literacy [ Time Frame: Baseline ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Mayo ClinicPhoenixArizona85054
Clinical Trials Referral Office
[email protected]
855-776-0015
Ewan K. Cobran, PhD (PRINCIPAL_INVESTIGATOR)
Mayo Clinic in FloridaJacksonvilleFlorida32224-9980
Clinical Trials Referral Office
[email protected]
855-776-0015
Folakemi Odedina, PhD (PRINCIPAL_INVESTIGATOR)
Mayo ClinicRochesterMinnesota55905
Clinical Trials Referral Office
[email protected]
855-776-0015
Christi A. Patten, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Phoenix, AZ

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
Mayo Clinic· Phoenix, AZMayo Clinic in Florida· Jacksonville, FLMayo Clinic· Rochester, MN

Related Studies